A 14-year-old presented with recurrent episodes of epistaxis along with characteristic skin and mucous membrane lesions. The lesions were seen at dorsum of tongue, oral cavity, buccal mucosa, lips, palate and nasal mucosa. Lab findings revealed normal coagulation profile. Which of the following drugs has been recently approved for the above condition: -
Bevacizumab Ranibizumab Transtuzumab Sorafenib